Drug
NOS F-18 clinical trials
- studies test it
- 5
- open now
- 1
- in phase 3
- 0
- first study started
- 2018
Keep track of what changes. Save the NOS F-18 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
5 studies that test it; most in 2019 (2)
| Year | Studies |
|---|---|
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 4
- Phase 1
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 5
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses NOS F-18 is read from its arms, and is right about nine times in ten.
Testing it · 5
- Imaging Sex Differences in Smoking-Induced Pulmonary InflammationRecruitingPhase 1University of PennsylvaniaNCT03721822Written as [18F]NOS
- Evaluation of Neuroinflammation in Parkinson's Disease Using 18F-NOS PET/CTActive, not recruitingEarly Phase 1University of PennsylvaniaNCT04062526Written as [18F]NOS
- Imaging Inflammation With Alcohol Use Disorder: an [18F]NOS StudyActive, not recruitingEarly Phase 1University of PennsylvaniaNCT05885594Written as [18F]NOS
- Evaluation of Neuroinflammation FNOS PET/CT in HIV (+) and (-) Subjects With OUD and Healthy ControlsActive, not recruitingEarly Phase 1University of PennsylvaniaNCT04401917Written as [18F]NOS
- Molecular Imaging of the Underlying Mechanism of Cardiotoxicity in Patients With Light Chain Amyloidosis Using PET/CTTerminatedEarly Phase 1University of PennsylvaniaNCT04105634Written as FNOS
Codes
What other systems call NOS F-18 · ClinicalTrials.gg INT018620
- UNII (FDA) YTN3P8TA3KNOS F-18One source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | YTN3P8TA3K | NOS F-18 | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.